These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 26847376)
1. ACMT Position Statement: Safety Issues Regarding Prescription Fentanyl Products. American College of Medical Toxicology J Med Toxicol; 2016 Jun; 12(2):211-2. PubMed ID: 26847376 [No Abstract] [Full Text] [Related]
2. ACMT Position Statement: The Use of Methadone as an Analgesic. American College Of Medical Toxicology J Med Toxicol; 2016 Jun; 12(2):213-5. PubMed ID: 26746475 [No Abstract] [Full Text] [Related]
3. Opioid toxicity as a result of oral/transmucosal administration of transdermal fentanyl patch. Bektas F; Eken C; Sayrac V Eur J Emerg Med; 2009 Dec; 16(6):344-5. PubMed ID: 19904081 [No Abstract] [Full Text] [Related]
4. FDA approvals of generic drugs: impact on the diversion of opioid analgesics with a potential for abuse. Inciardi JA; Surratt HL; Stivers Y; Cicero TJ J Opioid Manag; 2009; 5(2):81-7. PubMed ID: 19507804 [TBL] [Abstract][Full Text] [Related]
5. Fentanyl Formulations in the Management of Pain: An Update. Schug SA; Ting S Drugs; 2017 May; 77(7):747-763. PubMed ID: 28337672 [TBL] [Abstract][Full Text] [Related]
6. The fentanyl story. Stanley TH J Pain; 2014 Dec; 15(12):1215-26. PubMed ID: 25441689 [TBL] [Abstract][Full Text] [Related]
7. Oral transmucosal fentanyl: new preparation. For breakthrough cancer pain when morphine fails. Prescrire Int; 2002 Aug; 11(60):106-7. PubMed ID: 12199262 [TBL] [Abstract][Full Text] [Related]
8. A pitfall to avoid when starting a patient on transdermal fentanyl. Low JA; Chye R Aust Fam Physician; 2000 Dec; 29(12):1173-5. PubMed ID: 11140227 [TBL] [Abstract][Full Text] [Related]
9. Transdermal fentanyl: caution in the use of high doses. Botterman J; De Meester C; Eeckhaut K Palliat Med; 2004 Oct; 18(7):663. PubMed ID: 15540677 [No Abstract] [Full Text] [Related]
10. [The Danish Medicines Agency should reconsider the criteria of generic substitution between fentanyl depot patches]. Christrup LL; Jensen NH; Jonsson T; Sjøgren P; Steffansen B Ugeskr Laeger; 2009 Oct; 171(44):3215; author reply 3215. PubMed ID: 19866512 [No Abstract] [Full Text] [Related]
11. Shared risk evaluation mitigation strategy for all immediate-release transmucosal fentanyl dosage forms. Food And Drug Administration, Public Health Service, U.S. Department Of Health And Human Services J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):123-6. PubMed ID: 22764848 [TBL] [Abstract][Full Text] [Related]